Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-2026092045-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Kumar V Satish patents
Kumar V Satish is listed as an inventor on 53 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kumar V Satish |
| Total patents | 53 |
| First publication | Oct 15, 2015 |
| Latest publication | Apr 2, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Human plasma kallikrein inhibitors
US-2025270171-A1 · Aug 28, 2025 · US
Human plasma kallikrein inhibitors
US-2025257040-A1 · Aug 14, 2025 · US
Human plasma kallikrein inhibitors
US-12162838-B2 · Dec 10, 2024 · US
Human plasma kallikrein inhibitors
US-12116346-B2 · Oct 15, 2024 · US
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-2024294494-A1 · Sep 5, 2024 · US
Imidazole-containing inhibitors of ALK2 kinase
US-12054492-B2 · Aug 6, 2024 · US
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-12043610-B2 · Jul 23, 2024 · US
Human plasma kallikrein inhibitors
US-2024150296-A1 · May 9, 2024 · US
Human plasma kallikrein inhibitors
US-2024150295-A1 · May 9, 2024 · US
Recent patents
Latest publications not already listed above.
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-11866418-B2 · Jan 9, 2024 · US
Human plasma kallikrein inhibitors
US-11807605-B2 · Nov 7, 2023 · US
Imidazole-containing inhibitors of alk2 kinase
US-2023271975-A1 · Aug 31, 2023 · US
Human plasma kallikrein inhibitors
US-11708332-B2 · Jul 25, 2023 · US
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-11708347-B2 · Jul 25, 2023 · US
Human plasma kallikrein inhibitors
US-11708333-B2 · Jul 25, 2023 · US
Human plasma kallikrein inhibitors
US-11685721-B2 · Jun 27, 2023 · US
Imidazole-containing inhibitors of ALK2 kinase
US-11661426-B2 · May 30, 2023 · US
Prodrugs of kallikrein inhibitors
US-11618731-B2 · Apr 4, 2023 · US
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-2023099716-A1 · Mar 30, 2023 · US
Human plasma kallikrein inhibitors
US-2023094305-A1 · Mar 30, 2023 · US
Human plasma kallikrein inhibitors
US-2023100082-A1 · Mar 30, 2023 · US
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-2023072867-A1 · Mar 9, 2023 · US
Human plasma kallikrein inhibitors
US-2023056538-A1 · Feb 23, 2023 · US
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-2022356166-A1 · Nov 10, 2022 · US
Imidazole-containing inhibitors of alk2 kinase
US-2022332723-A1 · Oct 20, 2022 · US
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-11370774-B2 · Jun 28, 2022 · US
Human plasma kallikrein inhibitors
US-2022098151-A1 · Mar 31, 2022 · US
Human plasma kallikrein inhibitors
US-11230530-B2 · Jan 25, 2022 · US
Human plasma kallikrein inhibitors
US-11203574-B2 · Dec 21, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Biocryst Pharm Inc | 53 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D405/12 | 52 |
| C07D401/12 | 52 |
| A61P9/00 | 44 |
| A61P27/02 | 44 |
| A61P25/00 | 44 |